Colleen Hall

Articles

FDA Approves Skin Infection Antibiotic Medication

June 20, 2017

The FDA has approved delafloxacin (Baxdela, Melinta Therapeutics), a fluoroquinolone designed to treat adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria.